Christophe Mérieux Conference: New Trends in Tumor Virology
|
|
|
- Lesley Miller
- 6 years ago
- Views:
Transcription
1 Sunday 17 January Registration Welcome Address Guy VERNET - Fondation Mérieux Fabien ZOULIM - INSERM Opening Session Chaired by Christian Bréchot & Massimo Tommasino The history of tumor virology Poster Session How do retroviruses induce cancers? Harald ZUR HAUSEN University of Fribourg Ann SKALKA Fox Chase Cancer Centre Abstracts to be submitted by participants Welcome Dinner Monday 18 January 2010 Session 1 Epidemiology, public health impact, and pathobiology of virally-induced tumors Chaired by David Heymann & Christian Trépo Epidemiology of virus induced cancers: HPV/immune suppression setting (HIV, HHV8, EBV) Flash presentation: screening in low resource countries Natural history of viral hepatitis and link with hepatocellular carcinoma Clinical and Molecular Epidemiology of HHV-8 and Kaposi Sarcoma Silvia FRANCESCHI IARC Rengaswamy SANKARANARAYANAN - IARC Mickael KEW University of WitWatersrand Antoine GESSAIN Institut Pasteur
2 Session 2 Animal viruses and cancers Chaired by Jean-Christophe Audonnet & Ab Osterhaus Animal heath Hepadnavirus induced Hepatocellular carcinoma in animals Feline Leukemia virus Mastomys coucha, a natural rodent model to study the cutaneous and mucosal papillomavirus mediated carcinogenesis Ab OSTERHAUS Erasmus Medical Centre Marie-Annick BUENDIA Institut Pasteur Jim NEIL University of Glasgow Frank RÖSL Lunch Session 3 Tumor mechanisms 1: oncogenes Chaired by François-Loïc Cosset & Antoine Gessain Molecular mechanisms of EBV oncoproteins in human carcinogenesis Insights into the molecular oncogenic mechanisms of herpesvirusinduced lymphomas in chicken HTLV tax and adult T cell leukemoa The role of viral signal-transducing membrane proteins in the life cycle of Kaposi Sarcoma Virus Elliot KIEFF Harvard University Venugopal NAIR Imperial College Chou-Zen GIAM University of Connecticut Thomas SCHULZ Hannover Medical School
3 Session 4 Tumor mechanisms 2: epigenetic Chaired by Zdenko Herceg & Thomas Schulz Flash presentation: Cellular gene silencing by promoter methylation during progression of HPV-induced cervical diseases Genome methylation and histone acetylation regulation in chronic HBV and HCV infections: impact on hepatocyte transformation Telomerase and telosomic dysregulation during HTLV induced carcinogenesis Poster session (continued) Panel discussion of posters Matthias DÜRST Klinik für Geburtshilfe und Frauenheilkunde Massimo LEVRERO University of Rome Eric WATTEL Hôpital Edouard Herriot Abstracts to be submitted by participants Chairs: Pierre Jalinot & Patrice Marche Dinner Tuesday 19 January 2010 Session 5 Tumor mechanisms 3: tumor suppressors Chaired by Pierre Hainaut & Massimo Levrero hdlg tumour suppressor and related proteins are targeted by HPV E6 oncoproteins HBV X protein mediated dysregulation of p53 induced apoptosis Role of micrornas and tumor suppressors in HTLV induced cell growth dysregulation Lawrence BANKS ICGEB Ouriana ANDRISANI Purdue University Kuan Teh JEANG NIAID
4 Session 6 Tumor mechanisms 4: cell signaling Chaired by Kuan Teh Jeang & Vincent Lotteau Cell signalling and HTLV: how does HTLV evade the immune response? Regulation of TLR expression and functions by HPV (innate immunity evasion and HPV) HCV induced modification of hepatocyte metabolism and signalling: impact on viral persistence Charles BANGHAM Imperial College Massimo TOMMASINO IARC Ralf BARTENSCHLAGER University of Heidelberg Session 7 Prevention of cancer Chaired by Thomas Baumert & Jack Wands Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B Flash presentation: what s new with HCV vaccine? HPV prophylactic vaccine Impact of antiviral treatment of chronic hepatitis B and C on hepatocellular carcinoma prevention Ding-Shinn CHEN National Taiwan University Geneviève INCHAUSPE Transgene Lutz GISSMANN Fabien ZOULIM INSERM Lunch
5 Session 8 Therapy of virally induced cancers Chaired by Christophe Caux & Philippe Merle Targeted therapy for virus induced cancers; the example of hepatocellular carcinoma Immunotherapy of cancer: viral antigen as a target? Viruses as tools: oncolytic viruses for the therapy of cancers Jack WANDS Brown Medical School Cornelis J. MELIEF Leiden University Medical Center Jean ROMMELAERE Final Session Chaired by Cornelis J. Melief & Massimo Tommasino Identification of novel cancer associated viruses Conclusion Patrick S. MOORE University of Pittsburg Guy VERNET - Fondation Mérieux Fabien ZOULIM - INSERM
LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH
LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:
CELL BIOLOGY - CLUTCH CH CANCER.
!! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined
Viruses and cancer: Should we be more afraid?
Viruses and cancer: Should we be more afraid? Viruses and cancer: Should we be more afraid? During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development
CONTENTS NOTE TO THE READER... 1
CONTENTS NOTE TO THE READER.... 1 List of Participants... 3 PREAMBLE... 11 A. GENERAL PRINCIPLES AND PROCEDURES...11 1. Background...11 2. Objective and scope.....................................................................................
ENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS
ENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS Joint Graduate Seminar Depar tment of Microbiology The Chinese University of Hong Kong PhD Candidate: Zhang Chuqing Super visor: Professor Paul Chan
Do Viruses Play a Role in Childhood Leukaemia?
CHILDREN with LEUKAEMIA, 6 September 2004 Do Viruses Play a Role in Childhood Leukaemia? Robin A. Weiss Natural Bioweapons of Mass Destruction A Richter Scale of Viruses and Global Mortality HIV HBV +
UC Berkeley Berkeley Scientific Journal
UC Berkeley Berkeley Scientific Journal Title Can A Virus Cause Cancer: A Look Into The History And Significance Of Oncoviruses Permalink https://escholarship.org/uc/item/6c57612p Journal Berkeley Scientific
Emerging Oncogenic Viruses Programme
Emerging Oncogenic Viruses Programme Wednesday 2 June 2010 Arrival of participants Accommodation at the Hotel dei Bizantini 19:00-20:00 Registration Dinner 20:30 Thursday 3 June 2010 08:00-09:00 Registration
Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Major Principles (cont d) 4. Principle targets of genetic damage: 4 classes
1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:
Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to
VIRUSES AND CANCER Michael Lea
VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review
Human Oncogenic Viruses Downloaded from by on 11/19/17. For personal use only.
This page intentionally left blank 6959tpCast.indd 2 12/4/09 10:48:47 AM Published by World Scientific Publishing Co. Pte. Ltd. 5 Toh Tuck Link, Singapore 596224 USA office: 27 Warren Street, Suite 401-402,
Cours Pasteur. Molecular Cancer Genetics. September 18-29, 2017
Cours Pasteur Molecular Cancer Genetics September 18-29, 2017 Directors François CLEMENT-BIDARD Co-director, Institut Curie Hospital Jean-Pierre VARTANIAN Co-director, Institut Pasteur PROGRAM 2017-2018
Virology. Julia Szeptycki. Alternative Splicing in Human Tumor Viruses: A Therapeutic Target
Alternative Splicing in Human Tumor Viruses: A Therapeutic Target Virology Due: December 20, 2012 1 Introduction At the end of the 19 th century, viruses were classified as small infectious agents that
CLARA 2013 Flash talk. Uzma Hasan CR1 Claudia Zannetti (Post doc) Guillaume Roblot (EPHE) Issam Tout (pre-doc)
HPV16 and regulation of the innate immune response CLARA 2013 Flash talk Uzma Hasan CR1 Claudia Zannetti (Post doc) Guillaume Roblot (EPHE) Issam Tout (pre-doc) Carlos Romain (M2) U851/U1111 CIRI/U1111
ESTIMATING DISEASE BURDEN ASSOCIATED WITH ONCOGENIC VIRUSES ABSTRACT
ORIGINAL ARTICLE ESTIMATING DISEASE BURDEN ASSOCIATED WITH ONCOGENIC VIRUSES Kanwal Baloch 1, Ameer Afzal Memon 2, Ikram Din Ujjan 3, Furqan Ahmed Bhatti 4 1-4 Department of Pathology, Liaquat University
For any cancer and for infection-related cancer, immediate ART was associated with a lower cancer risk in the first three models but not in models D,
Immediate ART in START Cuts Risk of Infection-Linked Cancer About 75% Conference on Retroviruses and Opportunistic Infections (CROI), February 22-25, 2016, Boston Mark Mascolini People who started antiretroviral
Viruses. Rotavirus (causes stomach flu) HIV virus
Viruses Rotavirus (causes stomach flu) HIV virus What is a virus? A virus is a microscopic, infectious agent that may infect any type of living cell. Viruses must infect living cells in order to make more
DNA Tumour Viruses. Virology, Pathogenesis and Vaccines. caister.com/dnatv2. Sally Roberts. Edited by:
DNA Tumour Viruses Virology, Pathogenesis and Vaccines Edited by: Sally Roberts Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Vincent Drive,
COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16
COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand
Tumor Immunology. Tumor (latin) = swelling
Tumor Immunology Tumor (latin) = swelling benign tumor malignant tumor Tumor immunology : the study of the types of antigens that are expressed by tumors how the immune system recognizes and responds to
Update on Biology and Clinical Impact of Occult Hepatitis B Virus Infection
Update on Biology and Clinical Impact of Occult Hepatitis B Virus Infection Taormina-MeSSINA-Italy October 1 st 2 nd 2018 1 Update on Biology and Clinical Impact of Occult Hepatitis B Virus Infection Taormina-MeSSINA-Italy
Nucleic acid Strands Family Example Accession Base pairs
Table 16.1 Classification of viruses based on nucleic acid composition. Note that NCBI BioProject accessions begin PRJNA and typically encompass several segments. Adapted from Schaechter et al. (1999)
Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center
Cancer 101 Spring Family Cancer Retreat 4/18/15 Amish Shah, M.D. New Mexico Cancer Center Topics to cover What is Cancer? Screening Diagnosis/Staging Treatment Basics Clinical Trials Surveillance What
Chapter 9, Part 1: Biology of Cancer and Tumor Spread
PATHOPHYSIOLOGY Name Chapter 9, Part 1: Biology of Cancer and Tumor Spread I. Cancer Characteristics and Terminology Neoplasm new growth, involves the overgrowth of tissue to form a neoplastic mass (tumor).
Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement
Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement Fabien Zoulim Service d hépatologie, Hospices Civils de Lyon INSERM U1052, Cancer
For more information about how to cite these materials visit
Author(s): David Miller, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
REPORT ON THE RESEARCH UNIT: Virology Department
Research evaluation REPORT ON THE RESEARCH UNIT: Virology Department UNDER THE SUPERVISION OF THE FOLLOWING INSTITUTIONS AND RESEARCH BODIES: Institut Pasteur Institut National de la Santé et de la Recherche
Vaccine Intervention Against Virus-induced Tumours
Vaccine Intervention Against Virus-induced Tumours LEUKAEMIA AND LYMPHOMA RESEARCH Vaccine Intervention against Virus-induced Tumours Edited by J. M. Goldman Consultant Physician Royal Postgraduate Medical
15 & 16 January International Conference on the Management of Liver Diseases. Organised by Pr Patrick Marcellin
15 & 16 January 2018 PARIS - Palais des Congrès International Conference on the Management of Liver Diseases Organised by Pr Patrick Marcellin Organising Committee Blaise Kutala, Monelle Muntlak Hôpital
Mechanisms Of Viral Leukaemogenesis (Leukaemia And Lymphoma Research ; V. 1)
Mechanisms Of Viral Leukaemogenesis (Leukaemia And Lymphoma Research ; V. 1) If you are searching for a ebook Mechanisms of Viral Leukaemogenesis (Leukaemia and Lymphoma Research ; V. 1) in pdf format,
27-28 November, 2017 Paris, France Espace Saint-Martin
27-28 November, 2017 Paris, France Espace Saint-Martin 199 bis rue Saint-Martin, 75003 Paris Immuno-oncology research and the subsequent development of immunotherapies continue to progress rapidly. We
Paul Murray University of Birmingham
Paul Murray University of Birmingham College of Medical and Dental Sciences The people of the Midlands have every reason to be supremely proud of this great centre of healing, of teaching and of research.
Transplantation and oncogenic risk: the role of viruses
Transplantation and oncogenic risk: the role of viruses VIM 2014, Katoomba Associate Professor Angela Webster angela.webster@sydney.edu.au What can transplantation help us understand about infection and
What is DNA? DNA is a double helix formed by base pairs attached to a sugar-phosphate backbone.
What is DNA? DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person s body has the same DNA. Most DNA is located in the cell nucleus
CRC 992 Symposium on Medical Epigenetics 2018
CRC 992 Symposium on Medical Epigenetics 2018 Monday, March 12 th Wednesday, March 14 th Agenda Lecture Hall Otto-Krayer-Haus Albertstr. 25 79104 Freiburg, Germany Day 1 Monday, March 12 th 2018, 14:30-19:30
HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies
EASL HCC SUMMIT 2017 2-5 February 2017, Geneva, Switzerland Scientific Committee: Basic Programme: Tom Luedde, Germany Helen Reeves, United Kingdom Clinical Programme: Alejandro Forner, Spain Franco Trevisani,
Immune surveillance hypothesis (Macfarlane Burnet, 1950s)
TUMOR-IMMUNITÄT A.K. Abbas, A.H. Lichtman, S. Pillai (6th edition, 2007) Cellular and Molecular Immunology Saunders Elsevier Chapter 17, immunity to tumors Immune surveillance hypothesis (Macfarlane Burnet,
Isorce Nathalie, Testoni B., Luangsay S., Locatelli M., Zannetti C., Henry T., Hasan U., Zoulim F., Durantel D.
Activité antivirale de différents interférons (IFNs) et cytokines proinflammatoires dans des modèles pertinents d hépatocytes infectés par le virus de l hépatite B (HBV) Isorce Nathalie, Testoni B., Luangsay
This is a free sample of content from The Hepatitis B and Delta Viruses. Click here for more information on how to buy the book.
Index A Acute liver failure (ALF), viral hepatitis, 7 Adalimab, hepatitis B management in immunosuppression patients, 279 Alemtuzumab, hepatitis B management in immunosuppression patients, 280 ALF. See
Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration
Cancers 2014, 6, 2155-2186; doi:10.3390/cancers6042155 Review OPEN ACCESS cancers ISSN 2072-6694 www.mdpi.com/journal/cancers Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration Yan
number Done by حسام أبو عوض Lara Abdallat Dr. Maha
number 18 Done by حسام أبو عوض Lara Abdallat Dr. Maha Continuing with the causes of cancer development In the previous lecture, the effect of chemicals on the development of cancer was discussed. In this
Viruses associated with human cancer
Available online at www.sciencedirect.com Biochimica et Biophysica Acta 1782 (2008) 127 150 www.elsevier.com/locate/bbadis Review Viruses associated with human cancer Margaret E. McLaughlin-Drubin, Karl
INDIVIDUALIZED INFECTION MEDICINE THE FUTURE IS NOW
JUNE 21-23, 2017 HERRENHAUSEN PALACE, HANNOVER, GERMANY INDIVIDUALIZED INFECTION MEDICINE THE FUTURE IS NOW PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 2:00 p.m. Registration
3 rd course on BREAST CANCER: FROM CLINICS TO BIOLOGY June 19-23, 2017 Institut Curie - Training Unit - International Course
08/03/2017 Monday, june 19 th : Clinical management Chair: Roman Rouzier 10:15 Training Unit Welcome: practical aspects & coffee 10:30 11:15 11:15 11:45 Anne Vincent-Salomon & Roman Rouzier Mathilde His
International Hepatitis Symposium Heidelberg
16 th May 18 th May 2018 International Hepatitis Symposium Heidelberg Ralf Bartenschlager s 60 th Birthday Symposium (16 th ) AND International Symposium of the TRR179 (17 th to 18 th ) Confirmed Speakers:
NIH Public Access Author Manuscript Nat Rev Cancer. Author manuscript; available in PMC 2013 July 22.
NIH Public Access Author Manuscript Published in final edited form as: Nat Rev Cancer. 2010 December ; 10(12): 878 889. doi:10.1038/nrc2961. Why do viruses cause cancer? Highlights of the first century
19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.
VIRUSES Many diseases of plants and animals are caused by bacteria or viruses that invade the body. Bacteria and viruses are NOT similar kinds of micro-organisms. Bacteria are classified as living organisms,
Lecture 10 VIROLOGY Assistant prof.dr. Baheeja A. alkhalidi
Lecture 10 VIROLOGY Assistant prof.dr. Baheeja A. alkhalidi Viruses are microbes that REQUIRE a host cell to replicate. By themselves they cannot replicate. They border on the edge of living and non-living.
Available online at WSN 76 (2017) EISSN HPV Vaccines. Katarzyna Sitarz
Available online at www.worldscientificnews.com WSN 76 (2017) 209-215 EISSN 2392-2192 HPV Vaccines ABSTRACT Katarzyna Sitarz Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University,
Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa
WEDNESDAY, JANUARY 18 Concurrent Sessions 1-2 15:00-16:30 Cervical Cancer Ballroom East Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa Progress in scaling up cervical cancer
Viruses Associated with Human Cancer
Viruses Associated with Human Cancer Margaret E. Mclaughlin-Drubin, Karl Munger To cite this version: Margaret E. Mclaughlin-Drubin, Karl Munger. Viruses Associated with Human Cancer. BBA - Molecular Basis
July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM
www.paris-nash.org Dear Colleagues, We are delighted to announce the 4th Paris NASH Meeting to be held on July 5-6 th 2018. This international academic meeting is aimed to do a deep-dive into many aspects
Can Mechanism plus Statistical Relevance add up to Good Enough Causation?
Can Mechanism plus Statistical Relevance add up to Good Enough Causation? BSPS Conference 2009 14 th July 2009 University of East Anglia Brendan Clarke Department of Science and Technology Studies UCL
Multiple Choice Questions - Paper 1
Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could
Rethinkng the causes and prevention of breast cancer: a cross-disciplinary evolutionary framework
Rethinkng the causes and prevention of breast cancer: a cross-disciplinary evolutionary framework Paul W. Ewald Holly A Swain Ewald Department of Biology Program in Disease Evolution University of Louisville
Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia
1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia
Mastomys coucha: A natural animal model for papillomavirus-induced skin carcinogenesis
Mastomys coucha: A natural animal model for papillomavirus-induced skin carcinogenesis Kai Schaefer, Julia Nafz, Myriam Ibberson and Frank Rösl Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum,
Human papillomavirus and vaccination for cervical cancer
Human papillomavirus and vaccination for cervical cancer Dorothy Machalek Department of Microbiology and Infectious Diseases Royal Women s Hospital, Melbourne, Australia VIRUSES AND CANCER Responsible
VIRUSES AND BREAST CANCER
Pisa University Hospital University of Pisa Regione Toscana VIRUSES AND BREAST CANCER INTERNATIONAL WORKSHOP April 2-4, 2012 Palazzo Blu LUNGARNO GAMBACORTI, 9 PISA THE WORKSHOP IS IN THE FRAME OF THE
Are Immune Modulators Really Needed to Cure HBV infection?
Are Immune Modulators Really Needed to Cure HBV infection? Harry L.A. Janssen Francis Family Chair of Hepatology Director Toronto Centre for Liver Disease University Health Network University of Toronto,
III. Oncogenic RNA Viruses - HTLV-1 is associated with T cell Leukemia/lymphoma that is endemic in certain parts of Japan and the Caribbean - HTLV-1
III. Oncogenic RNA Viruses - HTLV-1 is associated with T cell Leukemia/lymphoma that is endemic in certain parts of Japan and the Caribbean - HTLV-1 has tropism for CD4+ T cell and human infection requires
Experimental Therapeutics I
Experimental Therapeutics I Mary Hitt 5142 Katz Group Centre mhitt@ualberta.ca; or Mary.Hitt@albertahealthservices.ca 1 Specific Topics for Today Preclinical and clinical testing Gene therapy Nonviral
HIV Vaccine Conference
HIV Vaccine Conference The B cell response to HIV and HIV vaccines: From broadly neutralizing to non-neutralizing antibodies In memory of Dr. Charles Mérieux Organized by Fondation Mérieux Les Pensières
Ch. 18 Regulation of Gene Expression
Ch. 18 Regulation of Gene Expression 1 Human genome has around 23,688 genes (Scientific American 2/2006) Essential Questions: How is transcription regulated? How are genes expressed? 2 Bacteria regulate
Cours Pasteur. Molecular Cancer Genetics. September 24 October 5, Directors Jean-Pierre VARTANIAN Institut Pasteur. Sarah WATSON Institut Curie
Cours Pasteur Molecular Cancer Genetics September 24 October 5, 2018 Directors Jean-Pierre VARTANIAN Institut Pasteur Sarah WATSON Institut Curie PROGRAM 2018-2019 Molecular Cancer Genetics Room 4 & Laboratory
Hepatitis B Virus infection: virology
Hepatitis B Virus infection: virology 167 Falk Symposium: Liver under constant attack from fat to viruses III Falk Gastro-Konferenz 17.-21. September 2008 Congress Centrum Mainz Maura Dandri Department
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
Review (V1) - The Hallmarks of Cancer
Review (V1) - The Hallmarks of Cancer Robert A. Weinberg 1 Review (V1) - The Hallmarks of Cancer 2 Review (V1) - Number of somatic mutations in human cancers Top: children vs. adults Numbers in parentheses
Cancer Key facts The problem Cancer causes
Cancer Key facts Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008 (1). Lung, stomach, liver, colon and breast cancer cause the most cancer
VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON
VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION
Review (V1) - The Hallmarks of Cancer
Review (V1) - The Hallmarks of Cancer Robert A. Weinberg 1 Review (V1) - The Hallmarks of Cancer 2 Review (V1) - Number of somatic mutations in human cancers Top: children vs. adults Numbers in parentheses
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES
Hepatitis B: Clinical Relevance of HBV cccdna
Hepatitis B: Clinical Relevance of HBV cccdna Fabien Zoulim Hepatology Department, Hospices Civils de Lyon INSERM U1052, Cancer Research Center of Lyon Lyon University, France What is cccdna? Covalently
Aging and Cancer in HIV
Aging and Cancer in HIV Ronald Mitsuyasu, MD Professor of Medicine Director, UCLA Center for Clinical AIDS Research and Education Group Chairman, AIDS Malignancy Consortium (AMC) Age distribution of HIV-infected
Hepatitis B Foundation 6 th Annual Princeton Workshop November 10 11, 2000 Doylestown, PA
6 th Annual Princeton Workshop November 10 11, 2000 Doylestown, PA Submitted by Timothy M. Block, Ph.D. President and Chief Scientific Advisor The 6th annual Princeton HBV Workshop was unique, even by
Viruses and Human Cancer
Viruses and Human Cancer Robin A Weiss Division of Infection & Immunity University College London Viruses: The Invisible Enemy Venice, 21 September 2010 Overview 1842: Domenico Rigoni-Stern, Verona: no
Global Strategies to Eliminate Hepatitis B (ICE-HBV) A/Prof Peter Revill Doherty Institute & ICE-HBV 3 December 2017
Global Strategies to Eliminate Hepatitis B (ICE-HBV) A/Prof Peter Revill Doherty Institute & ICE-HBV 3 December 2017 September 2016 ANRS + Doherty + International HBV Meeting created ICE-HBV Facilitated
Persistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
5 th Annual GABRIEL meeting 9-12 December, 2012 Les Pensières, Annecy, France
5 th Annual GABRIEL meeting 9-12 December, 2012 Les Pensières, Annecy, Organized by Fondation Mérieux With the participation of the «Réseau Science et Technique, Afrique Caraïbes de soutien à la lutte
4 th ONE-HEALTH COURSE. (Preliminary program)
4 th ONE-HEALTH COURSE (Preliminary program) 4-20 April 2016 Monday 4 April 2016 9h00-10h30 WEEK 1 WELCOME TO THE COURSE : PRESENTATION OF PROFESSORS AND STUDENTS Myriam ERMONVAL, Marc SAVEY & Noël TORDO
Section des Unités de recherche. Evaluation report. Research unit : Hepatitis C Virology. University Paris 5
Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology University Paris 5 February 2009 Section des Unités de recherche Evaluation report Research unit : Hepatitis C Virology
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
NIH Public Access Author Manuscript Discov Med. Author manuscript; available in PMC 2011 July 27.
NIH Public Access Author Manuscript Published in final edited form as: Discov Med. 2005 December ; 5(30): 520 526. A Biobehavioral Perspective of Tumor Biology Paige Green McDonald, Ph.D., M.P.H., Basic
Cancer Research at DKFZ 2016
Cancer Research at DKFZ 2016 Research Program Inflammation, Infection and Cancer Research Programs Research Programs The DKFZ covers the entire breadth of modern cancer research. Fields of research range
Persistent Infections
Persistent Infections Lecture 16 Virology W3310/4310 Spring 2013 1 Breaking Up Is Hard To Do Neil Sedaka 1962 2 Acute vs. Persistent Infections Acute - a natural infection that usually is rapid and self
Hepatitis C Virus and Cytokine Responses
Hepatitis C Virus and Cytokine Responses Eui-Cheol Shin, M.D., Ph.D. Laboratory of Immunology & Infectious Diseases (LIID), Graduate School of Medical Science & Engineering (GSMSE), KAIST Daejeon, Korea
Virology. Brochure. 4 th World Congress on. San Antonio, USA October 06-08, 2014
Brochure 4 th World Congress on Virology San Antonio, USA October 06-08, 2014 Conference Secretariat 5716 Corsa Ave., Suite 110, West Lake, Los Angeles, CA 91362-7354, USA Ph: +1-650-268-9744, Fax: +1-650-618-1414,
The Search for Infectious Causes of Human Cancers: Where and Why? Harald zur Hausen Deutsches Krebsforschungszentrum Heidelberg, Germany
The Search for Infectious Causes of Human Cancers: Where and Why? Harald zur Hausen Deutsches Krebsforschungszentrum Heidelberg, Germany Annual Global Cancer Incidence due to Infections 2 017 000 = 18.6%
2018 Kern Lipid Conference
2018 Kern Lipid Conference Metabolic Regulation of Immunity, Cardiometabolic Diseases and Cancer: New Therapeutic Approaches Monday, August 13, 2018 to Wednesday, August 15, 2018 - Vail, Colorado Organizers:
Oncogenes. Introduction. Viral-induced Tumours. Secondary article. Retroviruses. Amanda R Perry, Institute of Cancer Research, Sutton, Surrey, UK
Amanda R Perry, Institute of Cancer Research, Sutton, Surrey, UK Oncogenes are the activated forms of normal cellular genes whose protein products are involved in key signalling pathways governing cell
Vaccins anti-cancer. Claude Leclerc. 7 novembre 2011
Vaccins anti-cancer Claude Leclerc 7 novembre 2011 2010: FDA panel passes first cancer vaccine Cancer, a worldwide burden 1st cause of mortality in France In Europ, in 2006: - 1.7 million deaths from cancer
Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS
Prokaryotic Biology VIRAL STDs, HIV-1 AND AIDS Prokaryotic Biology FROM THE CDC VIRAL STDs, HIV-1 AND AIDS VIRAL STDs & CONTACT VIRAL DISEASES A. GENITAL HERPES & COLD SORES 1. HERPES SIMPLEX VIRUS-2 (HHV-2)
Chapter 20 Lecture Outline
Chapter 20 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. Permission required for reproduction
Epigenetics and Toxicology
Epigenetics and Toxicology Aline.deconti@fda.hhs.gov Division of Biochemical Toxicology National Center for Toxicology Research U.S.-Food and Drug Administration The views expressed in this presentation
Latency Strategies of Herpesviruses
Latency Strategies of Herpesviruses Latency Strategies of Herpesviruses Edited by Janos Minarovits National Center for Epidemiology Budapest, Hungary Eva Gonczol National Center for Epidemiology Budapest,
Adaptive Immunity. Lecture 14 Biology W3310/4310 Virology Spring Life is simple, but we insist on making it complicated CONFUCIUS
Adaptive Immunity Lecture 14 Biology W3310/4310 Virology Spring 2016 Life is simple, but we insist on making it complicated CONFUCIUS Host defenses Intrinsic - Always present in the uninfected cell - Apoptosis,
Cancer immunity and immunotherapy. General principles
1 Cancer immunity and immunotherapy Abul K. Abbas UCSF General principles 2 The immune system recognizes and reacts against cancers The immune response against tumors is often dominated by regulation or